nach oben

Medical Oncology

Erschienen in:

01.01.2021 | Original Paper

Short-term effects of a Paleolithic lifestyle intervention in breast cancer patients undergoing radiotherapy: a pilot and feasibility study

verfasst von: Rainer J. Klement, Petra S. Koebrunner, Kelley Krage, Michael M. Weigel, Reinhart A. Sweeney

Erschienen in: Medical Oncology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Evolutionary principles are rarely considered in clinical oncology. We here aimed to test the feasibility and effects of a dietary and physical activity intervention based on evolutionary considerations in an oncological setting. A total of 13 breast cancer patients referred to our clinic for curative radiotherapy were recruited for this pilot study. The women were supposed to undertake a “Paleolithic lifestyle” (PL) intervention consisting of a Paleolithic diet and daily outdoor activity of at least 30 min duration while undergoing radiotherapy. Body composition was measured weekly by bioimpedance analysis. Blood parameters were assessed before, during, and at the end of radiotherapy. A control group on an unspecified standard diet (SD) was assigned by propensity score matching. A total of eleven patients completed the study. The majority of patients (64%) reported feeling good or very good during the intervention. The intervention group experienced an average decrease of 0.4 kg body weight (p < 0.001) and 0.34 kg (p < 0.001) fat mass per week, but fat-free and skeletal muscle mass were not significantly affected. Vitamin D levels increased slightly from 23.8 (11–37.3) ng/ml to 25.1 (22.6–41.6) ng/ml (p = 0.053). β-hydroxybutyrate levels were significantly increased and triglycerides and free T3 hormone levels significantly reduced by the PL intervention. This pilot study shows that adoption of a PL intervention during curative radiotherapy of breast cancer patients is feasible and able to reduce fat mass. Daily outdoor activity could eliminate vitamin D deficiency (vitamin D < 20 ng/ml). Future studies are needed to confirm these findings.

Nur mit Berechtigung zugänglich

This threshold was chosen based on the conversion between p-values and minimum Bayes factors [36]. Bayes factors (or likelihood ratios in case of simple hypotheses) measure the strength of evidence between two competing hypotheses [37]. In exploratory analyses, a p-value of 0.01 corresponds to a minimum Bayes factor of 1/6.5, providing moderate-strong evidence against the null hypothesis [36].

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.CrossRefPubMed

Chang-Claude J, Eby N, Kiechle M, Bastert G, Becher H. Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control. 2000;11:687–95.CrossRefPubMed

Fiolet T, Srour B, Sellem L, Kesse-Guyot E, Allès B, Méjean C, et al. Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort. BMJ. 2018;360:k322. https://doi.org/10.1136/bmj.k322.CrossRefPubMedPubMedCentral

Loprinzi PD, Cardinal BJ, Smit E, Winters-Stone KM. Physical activity and breast cancer risk. J Exerc Sci Fit. 2012;10:1–7. https://doi.org/10.1016/j.jesf.2012.04.004.CrossRef

John EM, Schwartz GG, Koo J, Wang W, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol. 2007;166:1409–19. https://doi.org/10.1093/aje/kwm259.CrossRefPubMed

Makarova AM, Frascari F, Davari P, Gorouhi F, Dutt P, Wang L, et al. Ultraviolet radiation inhibits mammary carcinogenesis in an ER-negative murine model by a mechanism independent of Vitamin D3. Cancer Prev Res. 2018;11:383–91. https://doi.org/10.1158/1940-6207.CAPR-17-0195.CrossRef

Kloog I, Portnov BA, Rennert HS, Haim A. Does the modern urbanized sleeping habitat pose a breast cancer risk? Chronobiol Int. 2011;28:76–80. https://doi.org/10.3109/07420528.2010.531490.CrossRefPubMed

Muck BR, Trotnow S, Egger H, Hommel G. Altered carbohydrate metabolism in breast cancer and benign breast affections. Arch Gynakol. 1976;221:83–91. https://doi.org/10.1007/BF00667684.CrossRefPubMed

Stoll BA. Upper abdominal obesity, insulin resistance and breast cancer risk. Int J Obes. 2002;26:747–53. https://doi.org/10.1038/sj.ijo.0801998.CrossRef

10.

Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer mechanisms: cancer metabolism. J Clin Oncol. 2016;34:4277–83. https://doi.org/10.1200/JCO.2016.67.9712.CrossRefPubMedPubMedCentral

11.

Eaton SB, Konner M, Shostak M. Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med. 1988;84:739–49. https://doi.org/10.1016/0002-9343(88)90113-1.CrossRefPubMed

12.

Eaton SB, Pike MC, Short RV, Lee NC, Trussel J, Hatcher RA, et al. Women’s reproductive cancers in evolutionary context. Q Rev Biol. 1994;69:353–67.CrossRefPubMed

13.

Spitz J, Spitz A. Cancer, nutrition and more: the nature-deficit-effect and the origin of cancer; Abstracts of the Ninth International Conference of Anticancer Research. Anticancer Res. 2014;34:6181–2.

14.

Freese J, Klement RJ, Ruiz-Núñez B, Schwarz S, Lötzerich H. The sedentary (r)evolution: have we lost our metabolic flexibility? [version 2; referees: 2 approved, 1 approved with reservations]. F1000Research. 2018;6:1787. https://doi.org/10.12688/f1000research.12724.1.CrossRefPubMedCentral

15.

Greaves M. Nothing in cancer makes sense except…. BMC Biol. 2018;16:22. https://doi.org/10.1186/s12915-018-0493-8.CrossRefPubMedPubMedCentral

16.

Fathalla MF. Impact of reproductive evolutionary mismatch on women’s health and the need for action and research. Int J Gynecol Obstet. 2019;144:129–34. https://doi.org/10.1002/ijgo.12694.CrossRef

17.

Stefansson V. Cancer: disease of civilization? New York: Hill and Wang; 1960.

18.

Hoggan R. Considering wheat, rye, and barley proteins as aids to carcinogens. Med Hypotheses. 1997;49:285–8.CrossRefPubMed

19.

Lutz W. Leben ohne Brot. Die wissenschaftlichen Grundlagen der kohlenhydratarmen Ernährung. 16th ed. Informed; 2004.

20.

Fine EJ, Champ CE, Feinman RD, Márquez S, Klement RJ. An evolutionary and mechanistic perspective on dietary carbohydrate restriction in cancer prevention. J Evol Health. 2016;1:15. https://doi.org/10.15310/2334-3591.1036.CrossRef

21.

Lemke D, Klement RJ, Paul S, Spitz J. Die Paläoernährung und ihr Stellenwert für die Prävention und Behandlung chronischer Krankheiten [The Paleolithic Diet and its Significance for the Prevention and Treatment of Chronic Diseases]. Aktuel Ernahrungsmed. 2016;41:437–49.CrossRef

22.

de la O V, Zazpe I, Martínez JA, Santiago S, Carlos S, Zulet MÁ, et al. Scoping review of Paleolithic dietary patterns: a definition proposal. Nutr Res Rev. 2020. https://doi.org/10.1017/S0954422420000153.CrossRefPubMed

23.

O’Dea K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984;33:596–603.CrossRefPubMed

24.

Barone M, Turroni S, Rampelli S, Soverini M, D’Amico F, Biagi E, et al. Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context. PLoS ONE. 2019;14:e0220619. https://doi.org/10.1371/journal.pone.0220619.CrossRefPubMedPubMedCentral

25.

Whalen KA, McCullough M, Flanders WD, Hartman TJ, Judd S, Bostick RM. Paleolithic and Mediterranean diet pattern scores and risk of incident, sporadic colorectal adenomas. Am J Epidemiol. 2014. https://doi.org/10.1093/aje/kwu235.CrossRefPubMedPubMedCentral

26.

Tóth C, Clemens Z. Treatment of rectal cancer with the paleolithic ketogenic diet: a 24-months follow-up. Am J Med Case Rep. 2017;5:205–16. https://doi.org/10.12691/ajmcr-5-8-3.CrossRef

27.

Tóth C, Clemens Z. Halted progression of soft palate cancer in a patient treated with the Paleolithic ketogenic diet alone. Am J Med Case Rep. 2016;4:288–92. https://doi.org/10.12691/ajmcr-4-8-8.CrossRef

28.

Tóth C, Schimmer M, Zsófia C. Complete cessation of recurrent cervical intraepithelial neoplasia (CIN) by the Paleolithic ketogenic diet: a case report. J Cancer Res Treat. 2018;6:1–5. https://doi.org/10.12691/jcrt-6-1-1.CrossRef

29.

Tóth C, Dabóczi A, Chanrai M, Schimmer M, Horváth K, Clemens Z. 4-year long progression-free and symptom-free survival of a patient with recurrent glioblastoma multiforme: a case report of the Paleolithic ketogenic diet (PKD) used as a stand-alone treatment after failed standard oncotherapy. Preprints. 2020. https://doi.org/10.20944/preprints201912.0264.v2.CrossRef

30.

Holick MF, Jenkins M. Schützendes Sonnenlicht: Die heilsamen Kräfte der Sonne. 1st ed. Stuttgart: Karl F. Haug Verlag; 2005.

31.

Klement RJ, Sweeney RA. Impact of a ketogenic diet intervention during radiotherapy on body composition: II. Protocol of a randomised phase I study (KETOCOMP). Clin Nutr ESPEN. 2016;12:e1-6. https://doi.org/10.1016/j.clnesp.2015.11.001.CrossRefPubMed

32.

Klement RJ, Champ CE, Kämmerer U, Koebrunner PS, Krage K, Schäfer G, et al. Impact of a ketogenic diet intervention during radiotherapy on body composition: III—final results of the KETOCOMP study for breast cancer patients. Breast Cancer Res. 2020;22:94. https://doi.org/10.1186/s13058-020-01331-5.CrossRefPubMedPubMedCentral

33.

Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal. 2007;15:199–236. https://doi.org/10.1093/pan/mpl013.CrossRef

34.

Morgan SL, Winship C. Counterfactuals and causal inference. Methods and principles for social research. 2nd ed. Cambridge: Cambridge University Press; 2015.

35.

Klement RJ, Schäfer G, Sweeney RA. A ketogenic diet exerts beneficial effects on body composition of cancer patients during radiotherapy: an interim analysis of the KETOCOMP study. J Tradit Complement Med. 2020;10:180–7. https://doi.org/10.1016/j.jtcme.2019.03.007.CrossRefPubMed

36.

Held L, Ott M. On p-values and Bayes factors. Annu Rev Stat Its Appl. 2018;5:393–419.CrossRef

37.

Bandyopadhyay PS, Brittan G Jr, Taper ML. Belief, evidence, and uncertainty: problems of epistemic inference. 1st ed. Basel: Springer International Publishing; 2016. https://doi.org/10.1007/978-3-319-27772-1.CrossRef

38.

Ho DE, Imai K, King G, Stuart EA. MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42:1–28.CrossRef

39.

Gröber U, Spitz J, Reichrath J, Kisters K, Holick MF. Vitamin D: update 2013. From rickets prophylaxis to general preventive healthcare. Dermatoendocrinology. 2013;2013(5):331–47. https://doi.org/10.4161/derm.26738.CrossRef

40.

Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and covid-19 infections and deaths. Nutrients. 2020;12:988. https://doi.org/10.3390/nu12040988.CrossRefPubMedCentral

41.

Luxwolda MF, Kuipers RS, Kema IP, Dijck-Brouwer DAJ, Muskiet FAJ. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr. 2012;108:1557–61. https://doi.org/10.1017/S0007114511007161.CrossRefPubMed

42.

Champ CE, Ohri N, Klement RJ, Cantor M, Beriwal S, Glaser SM, et al. Assessing changes in the activity levels of breast cancer patients during radiation therapy. Clin Breast Cancer. 2018. https://doi.org/10.1016/j.clbc.2017.08.009.CrossRefPubMed

43.

Robinson PJ, Bell RJ, Davis SR. Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer. Maturitas. 2014. https://doi.org/10.1016/j.maturitas.2014.07.004.CrossRefPubMed

44.

Azrad M, Demark-Wahnefried W. The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep. 2014;3:9–15.CrossRefPubMedPubMedCentral

45.

de Menezes EVA, Sampaio HAC, Carioca AAF, Parente NA, Brito FO, Moreira TMM, et al. Influence of Paleolithic diet on anthropometric markers in chronic diseases: systematic review and meta-analysis. Nutr J. 2019;18:41.CrossRefPubMedPubMedCentral

46.

von Bibra H, Wulf G, St John Sutton M, Pfützner A, Schuster T, Heilmeyer P. Low-carbohydrate/high-protein diet improves diastolic cardiac function and the metabolic syndrome in overweight-obese patients with type 2 diabetes. IJC Metab Endocr. 2014;2:11–8. https://doi.org/10.1016/j.ijcme.2013.12.001.CrossRef

47.

Jönsson T, Granfeldt Y, Erlanson-Albertsson C, Ahrén B, Lindeberg S. A Paleolithic diet is more satiating per calorie than a Mediterranean-like diet in individuals with ischemic heart disease. Nutr Metab (Lond). 2010;7:85. https://doi.org/10.1186/1743-7075-7-85.CrossRef

48.

Jönsson T, Granfeldt Y, Lindeberg S, Hallberg A-C. Subjective satiety and other experiences of a Paleolithic diet compared to a diabetes diet in patients with type 2 diabetes. Nutr J. 2013;12:105. https://doi.org/10.1186/1475-2891-12-105.CrossRefPubMedPubMedCentral

49.

Gosby AK, Conigrave AD, Lau NS, Iglesias MA, Hall RM, Jebb SA, et al. Testing protein leverage in lean humans: a randomised controlled experimental study. PLoS ONE. 2011;6:e25929. https://doi.org/10.1371/journal.pone.0025929.CrossRefPubMedPubMedCentral

50.

Tome D. Criteria and markers for protein quality assessment—a review. Br J Nutr. 2012;108(Suppl):S222–9. https://doi.org/10.1017/S0007114512002565.CrossRefPubMed

51.

Caan BJ, Feliciano EMC, Kroenke CH. The importance of body composition in explaining the overweight paradox in cancer. Cancer Res. 2018;78:1906–13. https://doi.org/10.1158/0008-5472.CAN-17-3287.CrossRefPubMedPubMedCentral

52.

Perez-Martinez P, Alcala-Diaz JF, Delgado-Lista J, Garcia-Rios A, Gomez-Delgado F, Marin-Hinojosa C, et al. Metabolic phenotypes of obesity influence triglyceride and inflammation homoeostasis. Eur J Clin Invest. 2014;44:1053–64. https://doi.org/10.1111/eci.12339.CrossRefPubMed

53.

Reitz C, Guzman VA, Narkhede A, DeCarli C, Brickman AM, Luchsinger JA. Relation of dysglycemia to structural brain changes in a multiethnic elderly cohort. J Am Geriatr Soc. 2017;65:277–85. https://doi.org/10.1111/jgs.14551.CrossRefPubMed

54.

Shan H, Li P, Liu H, Nie B, Yin X, Zhang T, et al. Gray matter reduction related to decreased serum creatinine and increased triglyceride, Hemoglobin A1C, and low-density lipoprotein in subjects with obesity. Neuroradiology. 2019;61:703–10. https://doi.org/10.1007/s00234-019-02202-3.CrossRefPubMed

55.

Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, et al. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat. 2005;94:135–44. https://doi.org/10.1007/s10549-005-6654-9.CrossRefPubMed

56.

Lofterød T, Mortensen ES, Nalwoga H, Wilsgaard T, Frydenberg H, Risberg T, et al. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 2018;18:654. https://doi.org/10.1186/s12885-018-4568-2.CrossRefPubMedPubMedCentral

57.

Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95:727–48. https://doi.org/10.1152/physrev.00030.2014.CrossRefPubMedPubMedCentral

58.

Christodoulatos GS, Spyrou N, Kadillari J, Psallida S, Dalamaga M. The role of adipokines in breast cancer: current evidence and perspectives. Curr Obes Rep. 2019;8:413–33. https://doi.org/10.1007/s13679-019-00364-y.CrossRefPubMed

59.

Spreadbury I. Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesity. Diabetes Metab Syndr Obes. 2012;5:175–89.CrossRefPubMedPubMedCentral

60.

Konijeti GG, Kim N, Lewis JD, Groven S, Chandrasekaran A, Grandhe S, et al. Efficacy of the autoimmune protocol diet for inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:2054–60. https://doi.org/10.1097/MIB.0000000000001221.CrossRefPubMed

61.

Abbott RD, Sadowski A, Alt AG. Efficacy of the autoimmune protocol diet as part of a multi-disciplinary, supported lifestyle intervention for Hashimoto’s Thyroiditis. Cureus. 2019;11:1–33. https://doi.org/10.7759/cureus.4556.CrossRef

62.

Brenton JN, Banwell B, Bergqvist AGC, Lehner-Gulotta D, Gampper L, Leytham E, et al. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019;6:e565. https://doi.org/10.1212/NXI.0000000000000565.CrossRefPubMedPubMedCentral

63.

Tóth C, Clemens Z. Successful treatment of a patient with obesity, type 2 diabetes and hypertension with the Paleolithic ketogenic diet. Int J Case Rep Images. 2015;6:161–7. https://doi.org/10.5348/ijcri-201530-CR-10491.CrossRef

64.

Tóth C, Clemens Z. A child with type 1 diabetes mellitus (T1DM) successfully treated with the Paleolithic ketogenic diet: a 19-month insulin-freedom. Int J Case Rep Images. 2015;6:753–8. https://doi.org/10.5348/ijcri-2015121-CR-10582.CrossRef

65.

Jönsson T, Ahrén B, Pacini G, Sundler F, Wierup N, Steen S, et al. A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr Metab (Lond). 2006;3:39. https://doi.org/10.1186/1743-7075-3-39.CrossRef

66.

O’Hearn LA. Ketogenic diets, caloric restriction, and hormones. J Evol Health. 2018;2:13. https://doi.org/10.15310/2334-3591.1093.CrossRef

67.

Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Manjer J. Triiodothyronine levels in relation to mortality from breast cancer and all causes: a population-based prospective cohort study. Eur J Endocrinol. 2013;168:483–90. https://doi.org/10.1530/EJE-12-0564.CrossRefPubMed

68.

Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Manjer J. T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study. BMC Cancer. 2014;14:536. https://doi.org/10.1186/1471-2407-14-536.CrossRefPubMedPubMedCentral

Titel: Short-term effects of a Paleolithic lifestyle intervention in breast cancer patients undergoing radiotherapy: a pilot and feasibility study
verfasst von: Rainer J. Klement
Petra S. Koebrunner
Kelley Krage
Michael M. Weigel
Reinhart A. Sweeney
Publikationsdatum: 01.01.2021
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 1/2021
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-020-01443-0

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Short-term effects of a Paleolithic lifestyle intervention in breast cancer patients undergoing radiotherapy: a pilot and feasibility study

Abstract

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma

Bioinformatic analysis of dysregulated proteins in prostate cancer patients reveals putative urinary biomarkers and key biological pathways

Combined crizotinib and endocrine drugs inhibit proliferation, migration, and colony formation of breast cancer cells via downregulation of MET and estrogen receptor

Integration of gene expression data identifies key genes and pathways in colorectal cancer

LDLRAD2 promotes pancreatic cancer progression through Akt/mTOR signaling pathway

Saying goodbye to primary endocrine resistance for advanced breast cancer?

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Update Onkologie